Sort   by:  
 Page size 
UnknownDifferentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.

Background

There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2 infection (PASC).

Objective

To investigate clinical laboratory markers of SARS-CoV-2 and PASC.

Design

Propensity score-weighted linear regression models were fitted to evaluate d...
S-EPMC11408082 | biostudies-literature
TranscriptomicsTranscription profiling of Staphylococcus aureus in response to unsaturaed long chain free fatty acids
Data is also available from http://bugs.sgul.ac.uk/E-BUGS-68
ORGANISM(S): Staphylococcus aureus 
2009-02-04 | E-BUGS-68 | biostudies-arrayexpress
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Background

Casirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein, blocking viral entry into host cells. We aimed to evaluate the efficacy and safety of casirivimab and imdevimab a...
S-EPMC8830904 | biostudies-literature
UnknownThe personal human oral microbiome obscures the effects of treatment on periodontal disease.
Periodontitis is a progressive disease of the periodontium with a complex, polymicrobial etiology. Recent Next-Generation Sequencing (NGS) studies of the microbial diversity associated with periodontitis have revealed strong, community-level differences in bacterial assemblages associated with healt...
S-EPMC3906071 | biostudies-literature
Unknown
Not available
S-EPMC9829070 | biostudies-literature
UnknownCanadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update.
Not available
S-EPMC9828999 | biostudies-literature
UnknownEpigenetic and Metabolic Reprogramming of Fibroblasts in Crohn's Disease Strictures Reveals Histone Deacetylases as Therapeutic Targets.

Background and aims

No effective therapeutic intervention exists for intestinal fibrosis in Crohn's disease [CD]. We characterized fibroblast subtypes, epigenetic and metabolic changes, and signalling pathways in CD fibrosis to inform future therapeutic strategies.

Methods

We undertoo...
S-EPMC11147807 | biostudies-literature
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Background

Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the se...
S-EPMC7787219 | biostudies-literature
UnknownA global reference for caesarean section rates (C-Model): a multicountry cross-sectional study.

Objective

To generate a global reference for caesarean section (CS) rates at health facilities.

Design

Cross-sectional study.

Setting

Health facilities from 43 countries.

Population/sample

Thirty eight thousand three hundred and twenty-four women giving birth from 22 cou...
S-EPMC4873961 | biostudies-literature
Unknown2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.
Not available
S-EPMC5634725 | biostudies-literature
Sort   by:  
 Page size